| CAS: | 109552-15-0 | ||||||
| 分子式: | C3H21NNa2O12P2 2+ | ||||||
| 分子量: | 371.12 | ||||||
| 中文名称: |
| ||||||
| 英文名称: |
| ||||||
| 用途: | 帕米膦酸(Pamidronate)二钠五水合物是预防骨质疏松症的化合物。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||
| P884583 | MACKLIN | Pamidronate disodium pentahydrate | ≥98% | 521元/10mg; 1996元/50mg; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:2-8℃ 状态:白色固体 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000524 | Pamidronate disodium pentahydrate | European Pharmacopoeia (EP) Reference Standard | 1559.78元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 1492801 | USP | Pamidronate disodium | United States Pharmacopeia (USP) Reference Standard | 4828.92元/100 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 506600 | Sigma-Aldrich | Pamidronate, Disodium Salt-CAS 109552-15-0-Calbiochem | A potent and specific inhibitor of bone resorption that does not cause any significant detrimental effect on bone growth and mineralization at concentrations used. | 1633.58元/10 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A potent and specific inhibitor of bone resorption that does not cause any significant detrimental effect on bone growth and mineralization at concentrations used. Effective in a variety of conditions characterized by pathologically enhanced bone turnover, including Paget’s disease, hypercalcaemia of malignancy, osteolytic bone metastasis, steroid-induced osteoporosis, and idiopathic osteoporosis. Inhibits breast cancer cell growth by inducing cell death in vitro. Provided in hydrated form, contains five molecules of water. 包装 10 mg in Plastic ampoule 生化/生理作用 Primary Target 警告 Toxicity: Harmful & Carcinogenic / Teratogenic (E) 重悬 Following reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C. 其他说明 Fromigue, O., et al. 2000. J. Bone Miner. Res.15, 2211. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||